Arch Dis Child. Published Online First: 3 September 2007. doi:10.1136/adc.2006.114249
Papers |
Monitoring of concordance in growth hormone therapy
1 Addenbrooke's Hospital, United Kingdom
2 University of Cambridge, United Kingdom
* To whom correspondence should be addressed. E-mail: cla22{at}cam.ac.uk.
Accepted 31 July 2007
Abstract
Concordance with growth hormone therapy in 75 children was objectively assessed through data on GP prescriptions over 12-months. 23% missed >2 injections/week. Lower concordance was associated with: longer duration on GH therapy (p<0.005), lack of choice of delivery device (p<0.005), and short prescription durations (p<0.005), and predicted lower height velocities (p<0.05).
Keywords: concordance, growth hormone therapy, objective monitoring
Relevant Article
- Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?
- Petrou and McIntosh
Arch. Dis. Child. 2008 93: 95-97.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
-
Petrou, , McIntosh,
(2008). Measuring the benefits of growth hormone therapy in children: a role for preference-based approaches?. Arch. Dis. Child.
93: 95-97
[Full Text]
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



